1. HBW Insight
  2. >>Ingredients & Safety

Breast Cancer Study Finds Benefit From Aspirin Use Linked To DNA Profiles

 
• By Eileen Francis

Breast cancer mortality among women who regularly used aspirin decreased 22%-40% for those with unmethylated tumor promoter and progesterone receptor genes, while women with methylated tumor promoter had of 67% all-cause death risk, study finds. Researchers and editorial author say study underscores importance of looking at methylation profiles, or chemical changes, in tumor tissue DNA.

Woman's hand pours the medicine pills out of the bottle - Image

A history of regular aspirin use could be linked to a significantly lower breast cancer mortality for women with certain DNA characteristics, though it could conversely increase mortality in women with other DNA features, according to a study by University of North Carolina researchers.

Published in the American Cancer Society's Cancer journal, the observational study with data from 1,266 women with breast cancer –...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

‘We Must Have The Truth’ – Calls For UWWTD Review Intensify As Evidence Looks ‘Shaky’

 
• By David Ridley

The evidence underpinning the “polluter pays” principle of the revised Urban Wastewater Treatment Directive - which calls on Europe's pharmaceutical industry to cough up at least 80% of the cost of updating wastewater treatment facilities - is looking increasingly shaky, according to a new report.

More from HBW Insight

Poland’s Formeds Acquired By Private Equity

 
• By Tom Gallen

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

FDA Proposes Requiring Unit-Dose Packaging For Orally Disintegrating OTC Monograph Drugs

 
• By Malcolm Spicer

Marking most strident use of authorities it received in 2020 as part of an overhaul of monograph system, FDA publishes proposal to shift orally disintegrating formats to individual-dose packaging and a related proposal to minimize firms’ regulatory burden for making delivery format changes potential

TikTok Shop More Popular For Beauty Than Online Sephora, Shein – Survey

 
• By Eileen Francis

Social platforms like TikTok Shop have “completely reshaped product discovery, creating a new shopping paradigm” for beauty and taking share from traditional beauty retailers, according to retail brand experience agency ChangeUp, Inc.